Follow
Joshua R. Nugent
Joshua R. Nugent
Research Scientist I, Kaiser Permanente Division of Research
Verified email at kp.org
Title
Cited by
Cited by
Year
HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: a population-based study in rural Kenya and Uganda
CA Koss, DV Havlir, J Ayieko, D Kwarisiima, J Kabami, G Chamie, ...
PLoS medicine 18 (2), e1003492, 2021
462021
A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda: a cluster randomised trial
E Kakande, C Christian, LB Balzer, A Owaraganise, JR Nugent, W DiIeso, ...
The Lancet HIV 9 (9), e607-e616, 2022
112022
Type I error control for cluster randomized trials under varying small sample structures
JR Nugent, KP Kleinman
BMC medical research methodology 21, 1-7, 2021
112021
clusterPower: power calculations for cluster-randomized and cluster-randomized crossover trials, 2021
K Kleinman, A Sakrejda, J Moyer, J Nugent, N Reich, D Obeng
URL https://cran. r-project. org/web/packages/clusterPower/clusterPower. pdf …, 2021
62021
A demonstration of Modified Treatment Policies to evaluate shifts in mobility and COVID-19 case rates in US counties
JR Nugent, LB Balzer
American Journal of Epidemiology 192 (5), 762-771, 2023
52023
Lower than expected HIV incidence among men and women at elevated HIV risk in a population-based PrEP study in rural Kenya and Uganda: interim results from the SEARCH study
CA Koss, DV Havlir, J Ayieko, D Kwarisiima, J Kabami, M Atukunda, ...
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 23, 52-52, 2020
52020
Blurring cluster randomized trials and observational studies: Two-Stage TMLE for subsampling, missingness, and few independent units
JR Nugent, C Marquez, ED Charlebois, R Abbott, LB Balzer, ...
Biostatistics, kxad015, 2023
22023
Blurring cluster randomized trials and observational studies using Two-Stage TMLE to address sub-sampling, missingness, and minimal independent units
JR Nugent, C Marquez, ED Charlebois, R Abbott, LB Balzer
arXiv preprint arXiv:2208.09508, 2022
22022
Evaluating shifts in mobility and COVID-19 case rates in US counties: A demonstration of modified treatment policies for causal inference with continuous exposures
JR Nugent, LB Balzer
arXiv preprint arXiv:2110.12529, 2021
22021
SARS-CoV-2 Delta variant genomic variation associated with breakthrough infection in Northern California: A retrospective cohort study.
J Skarbinski, JR Nugent, MS Wood, L Liu, T Bullick, JM Schapiro, ...
J. infect. dis, 2023
12023
Impact of a community-wide HIV test and treat intervention on population-level tuberculosis transmission in rural Uganda
C Marquez, M Atukunda, J Nugent, E Charlebois, G Chamie, F Mwangwa, ...
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 25, 16-17, 2022
12022
Cluster RCT of a mid-level manager intervention to promote IPT uptake in Uganda
E Kakande, C Christian, LB Balzer, JR Nugent, W DiIeso, D Rast, ...
Topics in Antiviral Medicine, 27-27, 2022
12022
Estimation of Causal Effects in Complex Clustered Data
JR Nugent
12022
Development and external validation of a prediction model for colorectal cancer among patients awaiting surveillance colonoscopy following polypectomy
TR Levin, CD Jensen, AR Marks, D Schlessinger, V Liu, N Udaltsova, ...
Gastro Hep Advances, 2024
2024
On-and Off-Label Atypical Antipsychotic Prescription Trends Across a Nine-Year Period Among Adolescents Pre-to Post-COVID-19
B Costales, NE Slama, RB Penfold, JR Nugent, SR Spalding, SA Sterling, ...
Academic Pediatrics, 2024
2024
Community-Wide Universal Human Immunodeficiency Virus (HIV) Test and Treat Intervention Reduces Tuberculosis Transmission in Rural Uganda: A Cluster-Randomized Trial
C Marquez, M Atukunda, J Nugent, ED Charlebois, G Chamie, ...
Clinical Infectious Diseases, ciad776, 2024
2024
Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system
TC Chervo, EP Elkin, JR Nugent, E Valice, LB Amsden, IJ Ergas, ...
medRxiv, 2024.01. 31.24301674, 2024
2024
Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Genomic Variation Associated With Breakthrough Infection in Northern California: A Retrospective Cohort Study
J Skarbinski, JR Nugent, MS Wood, L Liu, T Bullick, JM Schapiro, ...
The Journal of Infectious Diseases 228 (7), 878-888, 2023
2023
Statistical Analysis Plan for Health Outcomes in Phase 1 of the SEARCH-IPT Study
LB Balzer, J Nugent, DV Havlir, G Chamie
arXiv preprint arXiv:2111.10467, 2021
2021
Managerial Autonomy in a Transition Economy—Determinants and Effects: Some Evidence from China's TVEs
C Hsiao, H Cheng, J Nugent, J Qiu
Pacific Economic Review 11, 341, 2006
2006
The system can't perform the operation now. Try again later.
Articles 1–20